Cynosur a News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.05.18	FMCSA Announces Clarifying Regulatory Guidance for Transportation of Agricultural Commodities, Personal Conveyance (PR Newswire)
08.08.17	Mylan Launches Avonza™ in India (PR Newswire)
31.07.17	John Hancock Premium Dividend Fund Notice To Shareholders -- Sources Of Distribution Under Section 19(a) (PR Newswire)
11.06.17	Long-Term Metformin Treatment Found to Reduce Risk of Heart Disease in Adults with Type 1 Diabetes (PR Newswire)
05.04.17	Merrimack Declares $140M Special Dividend in Connection with Recently Completed Asset Sale (PR Newswire)
22.03.17	Penn National Gaming Set to Join S&P SmallCap 600 (PR Newswire)
28.02.17	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cynosure, Inc. - CYNO (PR Newswire)
23.02.17	Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Cynosure, Natus Medical, and NovoCure (PR Newswire)
15.02.17	AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO (RTTNews)
15.02.17	Gainers & Losers Of The Day: GALT, CYNO, CARA, AVIR, OHRP... (RTTNews)
14.02.17	Cynosure Holding On To Substantial Gain After Initial Jump (RTTNews)
14.02.17	Hologic Unit To Commence Tender Offer To Acquire Cynosure Shares For $66.00/shr (RTTNews)
14.02.17	Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses (PR Newswire)
07.02.17	Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year (PR Newswire)
01.02.17	Gainers & Losers Of The Day: MNTA, BLCM, VSAR, TENX, DMTX... (RTTNews)
06.01.17	Cynosure to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7 (PR Newswire)
29.10.15	GILD Files NDA For HCV Medicine, Canada Gets MonaLisa Touch, APRI Awaits Data (RTTNews)
18.09.15	CANF Making Big Move, TGTX And FDA On The Same Page For CLL Trial, APRI On Watch (RTTNews)
28.07.15	Cynosure Q2 Results Top Estimates (RTTNews)
19.05.15	Cynosure Receives FDA 510(k) Clearance For SculpSure - Quick Facts (RTTNews)
25.02.15	ADMP Proves A Point, PETX Regains Drug Rights, CBAY Dips, NKTR On Watch (RTTNews)
13.01.15	Cynosure Names William Flannery Lead Director - Quick Facts (RTTNews)
19.11.14	AGIO's Stellar Run, ONVO's Much Awaited Day, CYTR Slides For A Reason (RTTNews)
25.09.14	ACOR Opens Wallet, CYNO Gets FDA Nod, INO To Advance Ebola Vaccine Study (RTTNews)
24.09.14	Cynosure Gets FDA Clearance To Market PicoSure For Treatment Of Wrinkles (RTTNews)
30.07.14	Cynosure Promotes Timothy Baker To President - Quick Facts (RTTNews)
29.07.14	Cynosure Q2 Results Top Estimates (RTTNews)
12.02.14	Cynosure Q4 Profit Rises (RTTNews)
14.01.14	Cynosure: PicoSure Laser Gets Marketing Authorization In Korea & Taiwan (RTTNews)
17.12.13	Cynosure Settles Patent Suits Against Tria Beauty (RTTNews)
06.11.13	Cynosure Gets Australian Regulatory To Market PicoSure - Quick Facts (RTTNews)
15.10.13	Cynosure To Host Third-Quarter 2013 Financial Results Conference Call On October 29 (PR Newswire)
05.08.13	Acquisitions, R&D Progress, and Financial Results - Research Report on Allergan, Cubist, CHS, Charles River Laboratories, and Cynosure (PR Newswire)
31.07.13	Cynosure Reports Second-Quarter 2013 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cynosure IncShs -A-

Aktien Top/Flop

Meistgelesene Nachrichten